Export 95 results:
Auteur Title Type [ Année(Desc)]
Filtres: Auteur is Norbert Schmitz  [Enlever les filtres]
Deschênes SS, Graham E, Kivimäki M, Schmitz N.  2018.  Adverse Childhood Experiences and the Risk of Diabetes: Examining the Roles of Depressive Symptoms and Cardiometabolic Dysregulations in the Whitehall II Cohort Study.. Diabetes Care.
Elgendy R, Deschênes SS, Burns RJ, Levy M, Schmitz N.  2018.  Alcohol consumption, depressive symptoms, and the incidence of diabetes-related complications.. J Diabetes.
Gariépy G, McIlwaine SV, Schmitz N, Shah JL.  2018.  An approach to sample size calculation for research on duration of untreated psychosis.. Schizophr Res.
Smith KJ, Au B, Ollis L, Schmitz N.  2018.  The association between C-reactive protein, Interleukin-6 and depression among older adults in the community: A systematic review and meta-analysis.. Exp Gerontol. 102:109-132.
Burns RJ, Deschênes SS, Schmitz N.  2018.  Associations between Depressive Symptoms and Indices of Obesity in Adults with Prediabetes and Normal Blood Glucose Levels: Results From the Emotional Health and Wellbeing Study.. Can J Diabetes.
Schmitz N, Deschênes SS, Burns RJ, Danna SM, Franco OH, M Ikram A, Kivimäki M, Singh-Manoux A, Tiemeier H.  2018.  Cardiometabolic dysregulation and cognitive decline: potential role of depressive symptoms.. Br J Psychiatry. 212(2):96-102.
Deschênes SS, Burns RJ, Schmitz N.  2018.  Comorbid depressive and anxiety symptoms and the risk of type 2 diabetes: Findings from the Lifelines Cohort Study.. J Affect Disord. 238:24-31.
Konsztowicz S, Schmitz N, Lepage M.  2018.  Dimensions of insight in schizophrenia: Exploratory factor analysis of items from multiple self- and interviewer-rated measures of insight.. Schizophr Res. 199:319-325.
Elgendy R, Deschênes SS, Burns RJ, Schmitz N.  2018.  Do mental disorders moderate the association between diabetes status and alcohol consumption? Psychol Health Med. 23(3):277-284.
Lutgens D, Joober R, Iyer SN, Lepage M, Norman R, Schmitz N, Mustafa S, Abadi S, Malla A.  2018.  Progress of negative symptoms over the initial 5 years of a first episode of psychosis - CORRIGENDUM.. Psychol Med. :1-3.
Sansfaçon J, Fletcher É, Zuroff DC, Schmitz N, Miller A, Israel M, Steiger H.  2018.  Psychometric properties of the "Autonomous and Controlled Motivation for Treatment Questionnaire" in women with eating disorders.. Eur Eat Disord Rev.
Deschênes SS, Burns RJ, Schmitz N.  2018.  Trajectories of anxiety symptoms and associations with incident cardiovascular disease in adults with type 2 diabetes.. J Psychosom Res. 104:95-100.
Levy M, Deschênes SS, Burns RJ, Elgendy R, Schmitz N.  2018.  Trajectories of social support in adults with type 2 diabetes: Associations with depressive symptoms and functional disability.. Int J Geriatr Psychiatry.
Burns RJ, Fillo J, Deschênes SS, Schmitz N.  2019.  Dyadic associations between physical activity and body mass index in couples in which one partner has diabetes: results from the Lifelines cohort study.. J Behav Med.
McGihon RE, Burns RJ, Deschênes SS, Schmitz N.  2019.  Longitudinal associations between number of cigarettes per day and depressive symptoms in adult smokers with type 2 diabetes: A path analysis approach.. J Psychosom Res. 125:109737.
Daneault J-G, Maraj A, Lepage M, Malla A, Schmitz N, Iyer SN, Joober R, Shah JL.  2019.  Medication adherence in first episode psychosis: the role of pre-onset subthreshold symptoms.. Acta Psychiatr Scand. 139(4):336-347.
Majnemer A, Rohlicek C, Dahan-Oliel N, Sahakian S, Mazer B, Maltais DB, Schmitz N.  2019.  Participation in leisure activities in adolescents with congenital heart defects. Developmental Medicine & Child NeurologyDevelopmental Medicine & Child NeurologyDev Med Child Neurol. n/a(n/a)
Lutgens D, Joober R, Iyer SN, Lepage M, Norman R, Schmitz N, Mustafa S, Abadi S, Malla A.  2019.  Progress of negative symptoms over the initial 5 years of a first episode of psychosis.. Psychol Med. 49(1):66-74.
Wang JL, MacQueen G, Patten S, Manuel D, Lashewicz B, Schmitz N.  2019.  A randomized controlled trial to examine the impacts of disclosing personalized depression risk information on the outcomes of individuals who are at high risk of developing major depression: a research protocol.. BMC Psychiatry. 19(1):285.